Abstract
Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Current Neuropharmacology
Title:Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Volume: 10 Issue: 3
Author(s): Antonio Siniscalchi, Luca Gallelli, Angelo Labate, Giovanni Malferrari, Caterina Palleria and Giovambattista De Sarro
Affiliation:
Keywords: Post-stroke, movement disorders, hyperkinetic movements disorders, hypokinetic movements disorders, GABA, Dopamine, post-stroke recovery
Abstract: Involuntary abnormal movements have been reported after ischaemic and haemorrhagic stroke. Post stroke movement disorders can appear as acute or delayed sequel. At the moment, for many of these disorders the knowledge of pharmacological treatment is still inadequate. Dopaminergic and GABAergic systems may be mainly involved in poststroke movement disorders. This article provides a review on drugs commonly used in post-stroke movement disorders, given that some post-stroke movement disorders have shown a partial benefit with pharmacological approach.
Export Options
About this article
Cite this article as:
Siniscalchi Antonio, Gallelli Luca, Labate Angelo, Malferrari Giovanni, Palleria Caterina and De Sarro Giovambattista, Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management, Current Neuropharmacology 2012; 10 (3) . https://dx.doi.org/10.2174/157015912803217341
| DOI https://dx.doi.org/10.2174/157015912803217341 |
Print ISSN 1570-159X |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Human Progenitor Cells for Bone Engineering Applications
Current Molecular Medicine Alterations of Sex Differentiation in Males: From Candidate Genes to Diagnosis and Treatments
Current Pharmaceutical Design Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies
Current Medicinal Chemistry The Efficacy of Psychological Therapies for Specific Phobias in Adults and Some Unanswered Questions
Current Psychiatry Reviews An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Metal Toxicity and Speciation: A Review
Current Medicinal Chemistry Control of Eosinophil Toxicity in the Lung
Current Drug Targets - Inflammation & Allergy β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia
Central Nervous System Agents in Medicinal Chemistry Understanding Recognition and Self-assembly in Biology using the Chemist´s Toolbox. Insight into Medicinal Chemistry
Current Topics in Medicinal Chemistry Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis
CNS & Neurological Disorders - Drug Targets Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance
Current Topics in Medicinal Chemistry A Dig Deep to Scout the Pharmacological and Clinical Facet of Garlic (<i>Allium sativum</i>)
Current Traditional Medicine Extracellular Citrate in Health and Disease
Current Molecular Medicine Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Link of COVID-19 and Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research Zolpidem Therapy for Movement Disorders
Recent Patents on CNS Drug Discovery (Discontinued)

